The UK’s National Health Service (NHS) is to review making high-dose statins available direct from pharmacists as part of its Long Term Plan to cut heart disease.
In a new review confirmed on Wednesday, England’s top pharmacist Keith Ridge and newly-appointed director of primary care, Nikki Kanani, will look at how the cholesterol-busting drugs could be provided by high street chemists.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze